Doxycycline for Cancer? Repurposed Antibiotic Targets Cancer Stem Cells + Metabolism (OXPHOS)

18 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
In this MMC Insights Podcast episode, we break down why doxycycline, a common tetracycline antibiotic, is being studied as a repurposed, metabolism-targeting therapy in cancer research. We explain the proposed “multi-pronged” mechanisms: how doxycycline may inhibit the cell’s mitochondrial energy pathway (OXPHOS / oxidative phosphorylation), what researchers mean by targeting cancer stem cells (CSCs) (including markers like CD44), and why this matters for treatment resistance and recurrence.

We also cover the “two-hit” concept often discussed in this research:
Hit #1: doxycycline stresses cancer cells by disrupting mitochondrial energy production
Hit #2: pairing with a metabolic strategy (commonly discussed alongside vitamin C) to reduce the cancer cell’s ability to switch to glycolysis (sugar-burning) as a backup fuel source.

Finally, we discuss why some studies explore doxycycline as a radiosensitizer (supporting radiation response through DNA repair pathway effects), and what parts of this topic are preclinical vs early clinical so you can interpret claims realistically.

Educational only — not medical advice. Do not start/stop antibiotics or supplements for cancer care without your oncology/medical team, and never use antibiotics outside a clinician-directed plan.

https://meakinmetaboliccare.com/
Categoria
Oncology
Commenta per primo questo video.

Prossimo